1. Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?
    Leonardo Marques da Fonseca et al, 2016, Front Oncol CrossRef
  2. Exposure to TNF-α combined with TGF-β induces carcinogenesis in vitro via NF-κB/Twist axis
    Weilei Dong et al, 2017 CrossRef
  3. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition
    Ming Liu et al, 2017, Anat. Rec. CrossRef
  4. FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β–mediated EMT in cervical cancer cells
    Motoharu Goto et al, 2017, Sci Rep CrossRef
  5. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma
    Hidenori Kusumoto et al, 2017, Cancer Sci CrossRef
  6. TRIM37 promotes epithelial‑mesenchymal transition in colorectal cancer.
    Cheng-En Hu et al, 2017, Mol Med Rep CrossRef
  7. Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition
    Danah S. Al-Hattab et al, 2018, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
  8. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p
    Xing Chen et al, 2018, J Cell Physiol CrossRef
  9. Long noncoding RNA HOTAIR knockdown inhibits autophagy and epithelial-mesenchymal transition through the Wnt signaling pathway in radioresistant human cervical cancer HeLa cells
    Xinggang Guo et al, 2018, J Cell Physiol CrossRef
  10. Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial–mesenchymal transition by suppressing the TGF-β/smad pathway via binding to GREM1
    Hui Miao et al, 2019, Cancer Cell Int CrossRef
  11. RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition
    Yong-Eun Kim et al, 2019, Oncogene CrossRef
  12. Quercetin modulates signaling pathways and induces apoptosis in cervical cancer cells
    Madhumitha Kedhari Sundaram et al, 2019, Biosci. Rep. CrossRef
  13. MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3
    Quan Zhou et al, 2016, Int J Gynecol Cancer CrossRef
  14. LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer
    Qing-Qing Chang et al, 2019 CrossRef
  15. Diabetic nephropathy execrates epithelial-to-mesenchymal transition (EMT) via miR-2467-3p/Twist1 pathway
    Yan Xu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  16. MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.
    Daozhi Xu et al, 2020, Cells CrossRef
  17. Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment
    Bernarda Majc et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  18. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma
    Chao Liu et al, 2018, Int J Mol Med CrossRef
  19. Small interfering RNA‑mediated knockdown of Twist attenuates the aggressive phenotypes of human endometrial carcinoma Ishikawa cells
    Yilian Pan et al, 2017, Exp Ther Med CrossRef
  20. Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis
    Hui-Chen Su et al, 2020, Sci Rep CrossRef
  21. Transcriptional analysis of cleft palate in TGFβ3 mutant mice
    J. Liu et al, 2020, Sci Rep CrossRef
  22. null
    Madhumitha Kedhari Sundaram et al, 2021 CrossRef
  23. Six-lncRNA Immune Prognostic Signature for Cervical Cancer
    Qian Chen et al, 2020, Front. Genet. CrossRef
  24. Dietary Isothiocyanates Inhibit Cancer Progression by Modulation of Epigenome
    Madhumitha Kedhari Sundaram et al, 2021, Seminars in Cancer Biology CrossRef
  25. lncRNA MIR210HG promotes the progression of endometrial cancer by sponging miR-337-3p/137 via the HMGA2-TGF-β/Wnt pathway
    Jian Ma et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
  26. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells
    Mohammad Panji et al, 2021, Gene CrossRef
  27. RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer
    Chieh-Ni Kao et al, 2021, JPM CrossRef
  28. LncRNA AFAP1-AS1/miR-27b-3p/VEGF-C axis modulates stemness characteristics in cervical cancer cells
    Meng Xia et al, 2021 CrossRef
  29. Cadherin Signaling in Cancer and Autoimmune Diseases
    Margherita Sisto et al, 2021, IJMS CrossRef
  30. The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways
    Michael J. Birrer et al, 2022, Front. Oncol. CrossRef
  31. Oxyresveratrol Reduces the Migration of Human Osteosarcoma Cell U2OS via Attenuating STAT3 Activation
    Tao Lv et al, 2022, Natural Product Communications CrossRef
  32. Comprehensive analysis of novel prognosis-related proteomic signature effectively improve risk stratification and precision treatment for patients with cervical cancer
    Xiaoyu Ji et al, 2022, Arch Gynecol Obstet CrossRef
  33. miR-181b targets semaphorin 3A to mediate TGF-β–induced endothelial-mesenchymal transition related to atrial fibrillation
    Ying-Ju Lai et al, 2022 CrossRef
  34. PODNL1 promotes cell migration and regulates the epithelial/mesenchymal transition process in bladder cancer
    Xiao Liu et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  35. Insights into therapy resistance in cervical cancer
    Irene A. George et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
  36. The Role of Cytokines in Epithelial–Mesenchymal Transition in Gynaecological Cancers: A Systematic Review
    Irene Ray et al, 2023, Cells CrossRef
  37. The Immunohistochemical Expression of Epithelial–Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer
    Aneta Popiel-Kopaczyk et al, 2023, IJMS CrossRef
  38. An m1A/m6A/m5C‐associated long non‐coding RNA signature: Prognostic and immunotherapeutic insights into cervical cancer
    Chenxiang Pan et al, 2023, The Journal of Gene Medicine CrossRef
  39. Exploring the prognostic significance of PKCε variants in cervical cancer
    Sameen Zafar et al, 2023, BMC Cancer CrossRef
  40. Shake It Up Baby Now: The Changing Focus on TWIST1 and Epithelial to Mesenchymal Transition in Cancer and Other Diseases
    Dureali Mirjat et al, 2023, IJMS CrossRef
  41. MicroRNA and gynecological cancers: Focus on miR-195
    Amirhossein Davoodvandi et al, 2023, Pathology - Research and Practice CrossRef
  42. Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer
    Ana Oaknin et al, 2024 CrossRef
  43. The possible correlation between miR-762, Hippo signaling pathway, TWIST1, and SMAD3 in lung cancer and chronic inflammatory diseases
    Neveen A. Hussein et al, 2024, Sci Rep CrossRef